Recombinant Human Ephrin-B2 Protein,hFc Tag
分享
收藏
推荐应用
产品介绍
The ephrins and EPH-related receptors comprise the largest subfamily of receptor protein-tyrosine kinases and have been implicated in mediating developmental events, especially in the nervous system and in erythropoiesis . Based on their structures and sequence relationships, ephrins are divided into the ephrin-A (EFNA) class, which are anchored to the membrane by a glycosylphosphatidylinositol linkage, and the ephrin-B (EFNB) class, which are transmembrane proteins .
Members of the ephrin cell-surface protein family interact with the Eph receptors, the largest family of receptor tyrosine kinases, mediating bi-directional signaling during tumorogenesis and various developmental events
产品性质
产品特色
高活性、高纯度、低内毒素、高批间一致性
应用案例
ELISA Data: Immobilized Human EphB2 His Tag at 2.0μg/mL (100μL/well) can bind Human Ephrin-B2 Fc Chimera with EC50 of 0.48-0.90ng/ml.
ELISA Data: Immobilized EphB6 His Tag,Human at 2.0μg/mL (100μL/well) can bind Ephrin-B2 Fc Chimera,
Human with EC50 of 0.22-0.39μg/ml.
ELISA Data: Immobilized Ephrin-B2 Fc Chimera Protein,Human at 2.0μg/mL (100μL/well) can bind EphB4 His Tag Protein,Human with EC50 of 0.15-0.27μg/mL.
SPR Data：Protein A Chip captured Human Ephrin-B2 Fc Chimera can bind Human EphB6 His Tag with an affinity constant of 0.20μM as determined in SPR assay.
SPR Data:Protein A Chip captured Human Ephrin-B2 Fc Chimera can bind Human EphB2 His Tag with an affinity constant of 23.71nM as determined in SPR assay.
存储条件
-25 ~ -15℃保存，收到货之后有效期1年。复溶后，无菌条件下，2~8℃保存，7天有效期。复溶后， 无菌条件下，-85 ~ -65℃保存，3个月有效期。
COA
已发表文献
推荐应用
【应用方向】HER2与HER3：ErbB受体家族协同靶向治疗的核心工具蛋白
89
2026-08-31
【应用方向】HER2：抗体药物研发的核心工具蛋白
81
2026-08-31
【应用方向】抗体药研发中常见靶点蛋白及其应用
108
2026-08-31
【应用方向】靶点蛋白在抗体药研发中的应用
89
2026-08-31
【应用方向】GPC3：HCC靶向治疗的核心靶点与药物研发探索
1814
2026-04-24
【应用方向】TROP2：从分子机制到实体瘤靶向治疗的研究进展
1800
2026-04-24
【应用方向】4-1BB-4-1BBL共刺激轴的T细胞活化机制
1087
2026-04-22
【应用方向】TNFR蛋白家族概述
1030
2026-04-21
【应用方向】Klotho蛋白：编织生命之线的抗衰老分子
1179
2026-04-20
【应用方向】药靶明星 | FGFRs家族蛋白解析
888
2026-04-20
【应用方向】解析Fc受体：抗体药物研发的核心靶点与评价基石
910
2026-04-20
【应用方向】FcγR家族：抗体药物研发的基石与核心靶点
948
2026-04-20
【应用方向】CD47-SIRPα轴研究工具与药物开发应用
824
2026-04-20
【技术讲解】ADC药物研究相关靶点汇总
19372
2025-07-30
【应用方向】抗体药筛选的关键—靶点蛋白
11563
2025-07-09
相关产品
推荐应用
联系我们
